INMD - INMODE ALERT: Bragar Eagel & Squire P.C. Announces that a Class Action Lawsuit Has Been Filed Against InMode Ltd. and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against InMode Ltd. ("InMode" or the "Company") (NASDAQ:INMD) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired InMode common stock between June 4, 2021 and October 12, 2023, both dates inclusive (the "Class Period"). Investors have until April 15, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
InMode is a global provider of aesthetic medical devices and technology, including devices purporting to offer body sculpting and other rejuvenation technologies. The Company's target customers include dermatologists, dentists, obstetricians and gynecologists, and medical spas.
The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and omissions concerning two topics that are of critical importance to investors: (1) the price at which InMode sells its devices, which reflects the demand for those products; and (2) InMode's compliance with U.S. Food and Drug Administration ("FDA") regulations, including the FDA's prohibition on off-label ...